Placeholder Banner

Will Smith to Deliver Keynote at 2016 BIO International Convention

May 13, 2016

Washington, D.C. (May 13, 2016) – Will Smith, the critically acclaimed star of the film “Concussion”, will headline the Biotechnology Innovation Organization’s (BIO) International Convention in San Francisco (June 6-9) with a keynote address and moderated discussion on Tuesday, June 7.  In “Concussion”, Smith played Dr. Bennet Omalu, best known for his discovery of chronic traumatic encephalopathy (CTE), a disorder caused by repeatedly hard hits to the head. The discovery has led to a nationwide discussion of the potential risks for both amateur and professional football players. Smith’s performance was nominated for several awards including a golden globe for Best Actor.

Omalu will also be in attendance with Smith for an interview with Jim Greenwood, BIO’s President and Chief Executive Officer. The conversation will explore what led Smith to take on the role of the forensic pathologist and Omalu’s research on CTE.

“It is an exciting opportunity to have Will Smith and Dr. Omalu at BIO’s 2016 International Convention,” said Greenwood. “Smith is universally known and respected, having excelled in so many areas of entertainment from acting to music to writing. I am looking forward to having a spirited and lively discussion with Mr. Smith and Dr. Omalu about their work.”

Smith has enjoyed a diverse career of music, television and film that has touched fans all over the globe and has garnered critical acclaim including five Golden Globe and two Academy award nominations, as well as four Grammy wins.

Tuesday’s Keynote session from 9-10:30AM (PT) is sponsored by Johnson & Johnson Innovation and is open to attendees with Convention Access or higher.

Advance media registration is now available for qualified reporters working full time for print, broadcast and web publications with valid press credentials. To register, please visit here. 

 

About BIO

BIO is the world's largest trade association representing biotechnology companies, academic institutions, state biotechnology centers and related organizations across the United States and in more than 30 other nations. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology products. BIO also produces the BIO International Convention, the world’s largest gathering of the biotechnology industry, along with industry-leading investor and partnering meetings held around the world. BIOtechNOW is BIO's blog chronicling “innovations transforming our world” and the BIO Newsletter is the organization’s bi-weekly email newsletter. Subscribe to the BIO Newsletter.

 

Upcoming BIO Events 

BIO International Convention
June 6-9, 2016
San Francisco, CA 

BIO Animal Biotech Summit
September 21-23, 2016
Bethesda, MD

BIO Investor Forum
October 18-19, 2016
San Francisco, CA

BIO Latin America Conference
October 26-28, 2016
Grand Hyatt São Paulo, Brazil

Discover More
BIO President & CEO John F. Crowley released the following statement:“A healthy and prosperous society is vitally important to the American people and to the world. The public health, economic security and our national security are best served…
“The Biotechnology Innovation Organization (BIO) applauds today's announcement from the USDA's Animal and Plant Health Inspection Service (APHIS) expanding the scope of biotechnology exemptions for modified plants under 7 CFR part 340. This…
BIO strongly supports a manufacturer’s ability to use a 340B rebate as an appropriate option to make 340B pricing available to covered entities."Manufacturers should have the choice to effectuate 340B pricing in the manner they deem most efficient…